BCR-ABL tyrosine kinase inhibitors

NVR TKI Pill - yellow capsule-shape, 22mm

Generic Name: nilotinib

Pill with imprint NVR TKI is Yellow, Capsule-shape and has been identified as Tasigna 200 mg. It is supplied by Novartis Pharmaceuticals.

Tasigna is used in the treatment of Chronic Myelogenous Leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Tasigna 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Tasigna (Nilotinib [ nye-loe-ti-nib ])-NVR TKI-200 mg-Yellow-Capsule-shape

Tasigna
Generic Name: nilotinib [ nye-loe-ti-nib ]
Imprint: NVR TKI
Strength: 200 mg
Color: Yellow
Size: 22.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: BCR-ABL tyrosine kinase inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00078-0526
Inactive Ingredients: Silicon dioxide, Crospovidone, Lactose monohydrate, Magnesium stearate, Poloxamer 188, Gelatin, Ferric oxide red, Ferric oxide yellow, Titanium dioxide,
Latest News
Related Drugs